These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1465947)

  • 1. Implementation of an effective program for quality assurance and quality control in living cell therapy: a 2-year experience with autolymphocyte therapy.
    du Moulin GC; Liu V; Osband ME
    Transplant Proc; 1992 Dec; 24(6):2803-8. PubMed ID: 1465947
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer immunotherapy using tumor-infiltrating lymphocytes.
    Figlin RA
    Semin Hematol; 1992 Apr; 29(2 Suppl 1):33-5. PubMed ID: 1535456
    [No Abstract]   [Full Text] [Related]  

  • 3. Autolymphocyte therapy for metastatic renal cell carcinoma: initial clinical results from 335 patients treated in a multisite clinical practice.
    Lavin PT; Maar R; Franklin M; Ross S; Martin J; Osband ME
    Transplant Proc; 1992 Dec; 24(6):3059-64. PubMed ID: 1466057
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cell therapy in renal cell carcinoma].
    Ravaud A
    Bull Cancer; 2003; 90(8-9):711-21. PubMed ID: 14609761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive cellular therapy.
    Hoffman DM; Gitlitz BJ; Belldegrun A; Figlin RA
    Semin Oncol; 2000 Apr; 27(2):221-33. PubMed ID: 10768601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evaluation of adoptive cell therapy for patients with metastatic renal cell carcinoma.
    Markel G; Cohen-Sinai T; Besser MJ; Oved K; Itzhaki O; Seidman R; Fridman E; Treves AJ; Keisari Y; Dotan Z; Ramon J; Schachter J
    Anticancer Res; 2009 Jan; 29(1):145-54. PubMed ID: 19331144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous activated lymphocyte therapy in a community hospital.
    Horváth J; Szabó-Szabari M; Sinkovics JG
    Acta Microbiol Immunol Hung; 1994; 41(2):205-14. PubMed ID: 7804724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
    Weidmann E; Logan TF; Yasumura S; Kirkwood JM; Trucco M; Whiteside TL
    Cancer Res; 1993 Oct; 53(20):4745-9. PubMed ID: 8402652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma.
    Bukowski RM; Sharfman W; Murthy S; Rayman P; Tubbs R; Alexander J; Budd GT; Sergi JS; Bauer L; Gibson V
    Cancer Res; 1991 Aug; 51(16):4199-205. PubMed ID: 1868441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autolymphocyte therapy in the treatment of metastatic renal cell carcinoma.
    Sawczuk IS
    Urol Clin North Am; 1993 May; 20(2):297-301. PubMed ID: 8493751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancer.
    Bouet-Toussaint F; Genetel N; Rioux-Leclercq N; Bansard JY; Levêque J; Guillé F; Patard JJ; Lesimple T; Catros-Quemener V
    Eur Cytokine Netw; 2000 Jun; 11(2):217-24. PubMed ID: 10903800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and safety of adoptive immunotherapy with ex vivo-generated autologous, cytotoxic T lymphocytes in patients with solid tumor.
    Montagna D; Turin I; Schiavo R; Montini E; Zaffaroni N; Villa R; Secondino S; Schiavetto I; Caliogna L; Locatelli F; Libri V; Pession A; Tonelli R; Maccario R; Siena S; Pedrazzoli P
    Cytotherapy; 2012 Jan; 14(1):80-90. PubMed ID: 21942841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer therapy with tumor-infiltrating lymphocytes: evaluation of potential and limitations.
    Whiteside TL
    In Vivo; 1991; 5(6):553-9. PubMed ID: 1810438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International forum on 'Perioperative blood salvage': a Spanish contribution.
    Muñoz M; Gómez-Luque A; Ramírez G;
    Vox Sang; 2007 Jan; 92(1):90. PubMed ID: 17181596
    [No Abstract]   [Full Text] [Related]  

  • 15. Development and implementation of delivery and quality control system for cellular therapies: experience in 500 patients.
    Miesowicz F; du Moulin G; Liu V; Hamilton D; Davies B; Pitkin Z; Stack J; Chew-Darke J; Osband M
    Cell Transplant; 1994; 3 Suppl 1():S53. PubMed ID: 8162310
    [No Abstract]   [Full Text] [Related]  

  • 16. Cellular therapy: scientific rationale and clinical results in the treatment of metastatic renal-cell carcinoma.
    Pierce WC; Belldegrun A; Figlin RA
    Semin Oncol; 1995 Feb; 22(1):74-80. PubMed ID: 7855622
    [No Abstract]   [Full Text] [Related]  

  • 17. Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma.
    Donskov F; Bennedsgaard KM; Hokland M; Marcussen N; Fisker R; Madsen HH; Fode K; von der Maase H
    Cancer Immunol Immunother; 2004 Aug; 53(8):729-39. PubMed ID: 15088127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive immunotherapy of renal cell carcinoma: studies from the Surgery Branch, National Cancer Institute.
    Linehan WM; Walther MM; Alexander RB; Rosenberg SA
    Semin Urol; 1993 Feb; 11(1):41-3. PubMed ID: 8465127
    [No Abstract]   [Full Text] [Related]  

  • 19. [TIL (tumor-infiltrating lymphocytes): a new therapeutic approach for metastasizing kidney cancer].
    Thiounn N; Peyret C; Flam T; Zerbib M; Debré B
    Rev Med Suisse Romande; 1992 Nov; 112(11):957-61. PubMed ID: 1462086
    [No Abstract]   [Full Text] [Related]  

  • 20. Can we define the mechanism of antitumor response observed during clinical adoptive immunotherapy?
    Merrouche Y; Négrier S; Puisieux I; Favrot M
    J Natl Cancer Inst; 1997 Sep; 89(18):1380. PubMed ID: 9308709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.